Orthologous proteins of experimental de- and remyelination are differentially regulated in the CSF proteome of multiple sclerosis subtypes
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Orthologous proteins of experimental de- and remyelination are differentially regulated in the CSF proteome of multiple sclerosis subtypes
Authors
Keywords
Multiple sclerosis, Cerebrospinal fluid, Gene expression, Proteomes, Inflammation, Gene regulation, Microglial cells, Transcriptome analysis
Journal
PLoS One
Volume 13, Issue 8, Pages e0202530
Publisher
Public Library of Science (PLoS)
Online
2018-08-17
DOI
10.1371/journal.pone.0202530
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of blood and CSF biomarkers in the evaluation of new treatments against multiple sclerosis
- (2017) Jan Lycke et al. Expert Review of Clinical Immunology
- Loss of Gas6 and Axl signaling results in extensive axonal damage, motor deficits, prolonged neuroinflammation, and less remyelination following cuprizone exposure
- (2017) Alex K. Ray et al. GLIA
- The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
- (2017) Susanne Krasemann et al. IMMUNITY
- TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy
- (2017) Cheryl E. G. Leyns et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TREM2, Microglia, and Neurodegenerative Diseases
- (2017) Felix L. Yeh et al. TRENDS IN MOLECULAR MEDICINE
- The role of interleukin-6 signaling in nervous tissue
- (2016) Michelle Rothaug et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- In-Depth Cerebrospinal Fluid Quantitative Proteome and Deglycoproteome Analysis: Presenting a Comprehensive Picture of Pathways and Processes Affected by Multiple Sclerosis
- (2016) Ann Cathrine Kroksveen et al. JOURNAL OF PROTEOME RESEARCH
- CSF-PR 2.0: An Interactive Literature Guide to Quantitative Cerebrospinal Fluid Mass Spectrometry Data from Neurodegenerative Disorders
- (2016) Astrid Guldbrandsen et al. MOLECULAR & CELLULAR PROTEOMICS
- Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study
- (2016) Katalin T Kovacs et al. Multiple Sclerosis Journal
- Label-free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis
- (2016) Jill A. Opsahl et al. PROTEOMICS
- Untangling the brain’s neuroinflammatory and neurodegenerative transcriptional responses
- (2016) Karpagam Srinivasan et al. Nature Communications
- Human iPSC-Derived Immature Astroglia Promote Oligodendrogenesis by Increasing TIMP-1 Secretion
- (2016) Peng Jiang et al. Cell Reports
- Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study
- (2016) Katalin T Kovacs et al. Multiple Sclerosis Journal
- TREM2 regulates microglial cell activation in response to demyelination in vivo
- (2015) Claudia Cantoni et al. ACTA NEUROPATHOLOGICA
- TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
- (2015) Yaming Wang et al. CELL
- Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis
- (2015) Dusanka S. Skundric et al. CYTOKINE
- Pathological mechanisms in progressive multiple sclerosis
- (2015) Don H Mahad et al. LANCET NEUROLOGY
- TIMP-1 couples RhoK activation to IL-1β-induced astrocyte responses
- (2015) Kasey M. Johnson et al. NEUROSCIENCE LETTERS
- Focal MMP-2 and MMP-9 Activity at the Blood-Brain Barrier Promotes Chemokine-Induced Leukocyte Migration
- (2015) Jian Song et al. Cell Reports
- Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study
- (2014) Pascal F. Durrenberger et al. JOURNAL OF NEURAL TRANSMISSION
- Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis
- (2014) Ilana Katz Sand et al. Multiple Sclerosis Journal
- Modules, networks and systems medicine for understanding disease and aiding diagnosis
- (2014) Mika Gustafsson et al. Genome Medicine
- Disease-specific molecular events in cortical multiple sclerosis lesions
- (2013) Marie Therese Fischer et al. BRAIN
- Recent progress in omics-driven analysis of MS to unravel pathological mechanisms
- (2013) Arjan Malekzadeh et al. Expert Review of Neurotherapeutics
- Tissue Inhibitor of Metalloproteinase 1 Is Preferentially Expressed in Th1 and Th17 T-Helper Cell Subsets and Is a Direct Stat Target Gene
- (2013) Adewole Adamson et al. PLoS One
- NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury
- (2012) Marie T. Fischer et al. BRAIN
- Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice
- (2012) May H. Han et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM
- (2012) Ann C. Kroksveen et al. Journal of Proteomics
- Identification and quantification of differentially expressed proteins in plasma of spinocerebellar ataxia type 12
- (2012) Vishnu Swarup et al. NEUROSCIENCE RESEARCH
- Loss of the receptor tyrosine kinase Axl leads to enhanced inflammation in the CNS and delayed removal of myelin debris during Experimental Autoimmune Encephalomyelitis
- (2011) Jason G Weinger et al. Journal of Neuroinflammation
- Matrix Metalloproteinases and Their Tissue Inhibitors in Cuprizone-Induced Demyelination and Remyelination of Brain White and Gray Matter
- (2011) Jelena Škuljec et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Evidence for a two-stage disability progression in multiple sclerosis
- (2010) E. Leray et al. BRAIN
- Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death
- (2010) S. Veto et al. BRAIN
- Apolipoproteins in the brain: implications for neurological and psychiatric disorders
- (2010) David A Elliott et al. Clinical Lipidology
- Contribution of Astrocyte-Derived IL-15 to CD8 T Cell Effector Functions in Multiple Sclerosis
- (2010) P. Saikali et al. JOURNAL OF IMMUNOLOGY
- Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials
- (2010) D. Bates NEUROLOGY
- The cuprizone animal model: new insights into an old story
- (2009) Markus Kipp et al. ACTA NEUROPATHOLOGICA
- Up-Regulation of Soluble Axl and Mer Receptor Tyrosine Kinases Negatively Correlates with Gas6 in Established Multiple Sclerosis Lesions
- (2009) Jason G. Weinger et al. AMERICAN JOURNAL OF PATHOLOGY
- Axl−/− mice have delayed recovery and prolonged axonal damage following cuprizone toxicity
- (2008) Hannah J. Hoehn et al. BRAIN RESEARCH
- MHC class II exacerbates demyelination in vivo independently of T cells
- (2008) Meenaxi M. Hiremath et al. JOURNAL OF NEUROIMMUNOLOGY
- Elevated Matrix Metalloproteinase-9 and Degradation of Perineuronal Nets in Cerebrocortical Multiple Sclerosis Plaques
- (2008) Elizabeth Gray et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Gas6 Deficiency Increases Oligodendrocyte Loss and Microglial Activation in Response to Cuprizone-Induced Demyelination
- (2008) M. D. Binder et al. JOURNAL OF NEUROSCIENCE
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
- Tissue Inhibitors of Metalloproteinases in Cell Signaling: Metalloproteinase-Independent Biological Activities
- (2008) W. G. Stetler-Stevenson Science Signaling
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started